{"id":"arterolane","rwe":[{"pmid":"41277377","year":"2025","title":"A systematic review and meta-analysis of clinical trials comparing arterolane-piperaquine vs. artemether-lumefantrine for the treatment of uncomplicated falciparum malaria.","finding":"","journal":"Journal of postgraduate medicine","studyType":"Clinical Study"},{"pmid":"41033576","year":"2025","title":"Arterolane and piperaquine Vs. artemether and lumefantrine in uncomplicated malaria: A randomized study in Nigeria.","finding":"","journal":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","studyType":"Clinical Study"},{"pmid":"37907954","year":"2023","title":"The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use.","finding":"","journal":"Parasites & vectors","studyType":"Clinical Study"},{"pmid":"35706363","year":"2022","title":"Comprehensive metabolite identification study of arterolane using hydrophilic interaction liquid chromatography with quadrupole-time-of-flight mass spectrometry.","finding":"","journal":"Rapid communications in mass spectrometry : RCM","studyType":"Clinical Study"},{"pmid":"35056117","year":"2022","title":"The Role of the Iron Protoporphyrins Heme and Hematin in the Antimalarial Activity of Endoperoxide Drugs.","finding":"","journal":"Pharmaceuticals (Basel, Switzerland)","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"P01BX02","category":"atc"},{"label":"Active","category":"status"},{"label":"Falciparum malaria","category":"indication"}],"phase":"marketed","safety":{"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=ARTEROLANE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:36:00.432827+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:36:06.508085+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ARTEROLANE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:36:07.002661+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL580910/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:36:07.733841+00:00"}},"allNames":["arterolane","arterolane maleate","OZ277","OZ 277"],"offLabel":[],"synonyms":["arterolane","arterolane maleate","OZ277","OZ 277"],"timeline":[{"date":"2012-03-09","type":"positive","source":"DrugCentral","milestone":"CDSCO (INDIA) approval"}],"ecosystem":[{"indication":"Falciparum malaria","otherDrugs":[{"name":"artesunate","slug":"artesunate","company":"Amivas"},{"name":"atovaquone","slug":"atovaquone","company":""},{"name":"chloroquine","slug":"chloroquine","company":"Sanofi Aventis Us"},{"name":"halofantrine","slug":"halofantrine","company":"Glaxosmithkline"}],"globalPrevalence":240000}],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Arterolane is a dihydroorotate dehydrogenase inhibitor, which means it blocks the malaria parasites' ability to synthesize pyrimidine nucleotides, a crucial step in their growth and replication."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/5090","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=ARTEROLANE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ARTEROLANE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:49:51.498478","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:36:09.991764+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"halofantrine","drugSlug":"halofantrine","fdaApproval":"1992-07-24","patentStatus":"Unknown","relationship":"same-class"}],"genericName":"arterolane","indications":{"approved":[{"name":"Falciparum malaria","source":"DrugCentral","snomedId":62676009,"regulator":"FDA","usPrevalence":null,"globalPrevalence":240000,"prevalenceMethod":"curated","prevalenceSource":"Orphanet (European Medicines Agency2015[INST])"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"halofantrine","brandName":"halofantrine","genericName":"halofantrine","approvalYear":"1992","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT03452475","phase":"PHASE3","title":"Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan Children","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2018-03-07","conditions":["Plasmodium Falciparum"],"enrollment":219,"completionDate":"2019-06-03"},{"nctId":"NCT02461186","phase":"PHASE2,PHASE3","title":"Arterolane-PQP Versus DHA-PQP in Uncomplicated Falciparum Malaria in Eastern Myanmar","status":"WITHDRAWN","sponsor":"University of Oxford","startDate":"2015-06","conditions":["Uncomplicated Falciparum Malaria","Artemisinin-resistant"],"enrollment":0,"completionDate":"2017-06"},{"nctId":"NCT00362050","phase":"PHASE2","title":"RBx11160 Phase II Dose Ranging Study RBx/MMV05-06","status":"COMPLETED","sponsor":"Medicines for Malaria Venture","startDate":"2006-06","conditions":["Plasmodium Falciparum Malaria"],"enrollment":255,"completionDate":"2007-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"3N1TN351VB","CHEBI":"CHEBI:136054","INN_ID":"8663","UMLSCUI":"C2977963","chemblId":"CHEMBL580910","ChEMBL_ID":"CHEMBL570680","PUBCHEM_CID":"10475633","SECONDARY_CAS_RN":"959520-73-1","MESH_SUPPLEMENTAL_RECORD_UI":"C489136"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":43,"therapeuticAreas":["Rare Disease"],"atcClassification":{"source":"DrugCentral","atcCode":"P01BX02","allCodes":["P01BX02"]},"biosimilarFilings":[],"recentPublications":[{"date":"2025 Oct 1","pmid":"41277377","title":"A systematic review and meta-analysis of clinical trials comparing arterolane-piperaquine vs. artemether-lumefantrine for the treatment of uncomplicated falciparum malaria.","journal":"Journal of postgraduate medicine"},{"date":"2025 Dec","pmid":"41033576","title":"Arterolane and piperaquine Vs. artemether and lumefantrine in uncomplicated malaria: A randomized study in Nigeria.","journal":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases"},{"date":"2023 Oct 31","pmid":"37907954","title":"The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use.","journal":"Parasites & vectors"},{"date":"2022 Aug 30","pmid":"35706363","title":"Comprehensive metabolite identification study of arterolane using hydrophilic interaction liquid chromatography with quadrupole-time-of-flight mass spectrometry.","journal":"Rapid communications in mass spectrometry : RCM"},{"date":"2022 Jan 4","pmid":"35056117","title":"The Role of the Iron Protoporphyrins Heme and Hematin in the Antimalarial Activity of Endoperoxide Drugs.","journal":"Pharmaceuticals (Basel, Switzerland)"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"ARTEROLANE","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:36:09.991764+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}